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Abstract
Construction of synthetic genetic networks requires the assembly of DNA fragments encoding functional biological parts in a
definedorder. Yet thismaybecomea time-consumingprocedure. To address this technical bottleneck,wehave created a series
of Gateway shuttle vectors and an integration vector, which facilitate the assembly of artificial genes and their expression in the
buddingyeastSaccharomyces cerevisiae.Ourmethodenables the rapidconstructionof anartificial gene fromapromoter andan
open reading frame (ORF) cassette by one-step recombination reaction in vitro. Furthermore, the plasmid thus created can
readilybe introduced intoyeast cells to test theassembledgene’s functionality.As flexible regulatory componentsof a synthetic
genetic network, we also created new versions of the tetracycline-regulated transactivators tTA and rtTA by fusing them to the
auxin-inducible degron (AID). Using our gene assembly approach, we made yeast expression vectors of these engineered
transactivators, AIDtTA and AIDrtTA and then tested their functions in yeast. We showed that these factors can be regulated by
doxycycline and degraded rapidly after addition of auxin to the medium. Taken together, the method for combinatorial gene
assembly described here is versatile and would be a valuable tool for yeast synthetic biology.
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Introduction
Recent progress in synthetic biology has made it possible to
engineer gene regulatory networks with predictable behaviors [1].
Construction of de novo gene networks requires efficient assembly of
DNA sequences including promoters and ORFs encoding proteins
with defined functions. Yet such DNA assemblies are often time-
consuming, typically involving ad hoc procedures such as restriction
digestions and DNA ligations. An alternative method for gene
assembly is the multisite Gateway recombination cloning [2]. This
system enables rapid and highly efficient construction of an
expression vector containing multiple DNA fragments in vitro from
the so-called Entry clones and a Destination vector. A recent study
applied this cloning technology successfully to the yeast one-hybrid
system [3]. In this system a library of DNA bait sequences and
ORFs encoding the reporters (His3 and b-galactosidase) were
assembled in a one-step Gateway recombination reaction. The
cloned plasmids were then integrated at the HIS3 and URA3 loci
for screening [3–5]. However, the Gateway vectors for the one-
hybrid system were not designed as versatile plasmid vectors for
more general use to build artificial genes and introduce them into
yeast. Such vectors should facilitate the rapid characterization of
new promoter-ORF combinations prior to the synthesis of an
artificial genetic network in yeast.
In an effort to aid gene network construction in budding yeast
Saccharomyces cerevisiae, we have adopted an approach similar to the
one-hybrid system and created Gateway Destination vectors.
These new Destination vectors are based upon the pRS series of
yeast centromere plasmids [6] and an integration vector [7]. In
addition, we have constructed a set of Entry clones harboring
promoters and ORFs. An artificial gene from a promoter and an
ORF Entry clones can be assembled in a Destination vector by
one-step recombination reaction in vitro.
To increase the flexibility of regulation of synthetic genetic
networks in yeast, we engineered two transcriptional transactivators,
AIDtTA and AIDrtTA. Each of these are a fusion of well-
characterized functional protein domains, the auxin-inducible
degron (AID) [8] and the tetracycline-regulated transactivator (tTA
and rtTA) [9]. tTA activity is downregulated in the presence of
tetracyclineantibiotics suchasdoxycycline,whilertTAisactivatedby
the antibiotic. In the AID system, a plant hormone auxin binds to
Tir1,anF-boxprotein,which inturn inducesrapiddegradationof the
target protein fused to AID [8]. Using our Gateway vectors and the
recombination cloning method, we constructed expression vectors of
AIDtTA and AIDrtTA and tested their functions in yeast. We also
constructed a destabilized version of Venus (enhanced YFP) ORF,
yEVenus-Cln2PEST -NLS, to be expressed as a fluorescent reporter
protein. Taken together, these resources provide a technological
platform to assemble and test a new promoter-ORF combination
efficiently in yeast.
Results
Construction of Yeast Gateway Vectors for One-step
Gene Assembly
To construct Gateway Destination vectors for assembling a
promoter and an ORF, we cloned the DNA sequences for site-
specific recombination and terminators for gene expression into
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the pRS series of yeast centromere plasmids [6] and an integration
vector [7]. Table 1 is the list of Destination vectors created in this
study (see Materials and Methods for details). We also made a
collection of promoter and ORF Entry clones by Gateway BP
recombination reactions (Table 2). The constructed Destination
vectors (Fig. 1) can be recombined with a promoter Entry clone
and an open reading frame (ORF) Entry clone in a one-step
Gateway LR reaction in vitro (Fig. 2). These promoters and ORFs
were cloned in the Gateway Donor vectors in a specific direction
so that assembled genes in expression vectors are always in the
same orientation relative to the recombination sites, in the order of
attB2-[promoter]-attB5-[ORF]-attB1-[TEF or CYC1 terminator].
The attB5 sequence (59-CAACTTTTGTATACAAAGTTG-39)
has no noticeable side effect on the gene expression from vectors so
far created by this method. A recent study has also applied the
Gateway system successfully for a yeast one-hybrid system, in
which a single attB1 recombination sequence is created between a
promoter and an ORF as a by-product of the recombination event
[3–5]. The attB5 ‘scar’ left behind by LR reactions may therefore
be unlikely to interfere with the assembled gene’s expression.
One of the Destination vector we have created (pDEST375)
allows integration of the artificial gene made by a Gateway
recombination reaction at the MET15 locus (Fig. 3). This
construct is based on the integration vector pIS375, which allows
a single-copy integration of the gene at the MET15 locus [7]. The
integrated constructs are highly stable because a duplicated copy
of MET15 and the flanking plasmid sequences including the URA3
marker gene are removed by homologous recombination [7]
(Fig. 3). It enables a recycling of URA3 marker gene for subsequent
gene integrations at other loci in the genome. pDEST375 was used
for the integration of TEF-AIDrtTA gene (see below and Materials
and Methods for details). For the detailed description of this class
of integration/disintegration vectors, see Sadowski et al. [7].
We have performed a number of Gateway LR reactions using
these plasmids with various combinations of promoters and ORFs
to create Yeast/E. coli shuttle vectors. The vectors thus created for
this study are listed in Table 3. An example of the expression
vector CUP1-yEVenus-Cln2PEST -NLS construct (pCM25) is
shown in Fig. 4A. The CUP1 promoter can be induced by copper
[10,11]. yEVenus-Cln2PEST -NLS is a fusion of the enhanced
yellow fluorescent protein Venus (yEVenus), the Cln2PEST (which
destabilizes the protein fused to it [10]) and the SV40 nuclear
localization signal (NLS). The expression of the fluorescence
reporter yEVenus-Cln2PEST-NLS was observed after one hour
following the addition of the inducer copper nitrate (Fig. 4A,
middle panels). Similar level of fluorescence was also detected at
six hours (Fig. 4A, bottom panels). When the culture media was
replaced with the one without copper after induction for two
hours, the fluorescence disappeared by six hours after the initial
induction (data not shown). We compared the fluorescence
produced by yEVenus-Cln22PEST -NLS and yEVenus-NLS when
expressed by the constitutive promoter ADH1 (Fig. 4B, C). The
fluorescence by ADH1-yEVenus-Cln2PEST-NLS (Fig. 4B) was
much weaker than that by ADH1-yEVenus-NLS (Fig. 4C),
indicating that Cln2PEST indeed destabilizes yEVenus.
All but a few expression vectors have no non-specific effect on
the cell growth: we have found that the yeast cells with TEF-tTA
(pCG112), and TEF-AIDtTA (pCG106; described below) grow
poorly with an unknown reason (data not shown). It has been
reported that an autoregulatory construct of tTA with a TetO7
promoter causes cell growth retardation when introduced in the
hamster glioblastoma cell line HJC-15 [12]. The mechanism of
this delay of cell proliferation remains unclear.
Construction and Characterization of Tunable
Transactivators AIDtTA and AIDrtTA
To fuse an AID to the N-terminus of tTA and rtTA, we have
used a method that combines a Gateway BP reaction in vitro and a
homologous recombination in vivo in E. coli [13] (See Materials
and Methods for details). To verify the auxin-dependent degra-
dation of AIDtTA and AIDrtTA, the yeast strain (YS114) with an
integrated copy of O. sativa TIR1 gene (ADH1-OsTIR1) was
transformed with a vector harboring ADH1-AIDtTA gene
(pDHM19). The transformed cells were grown in liquid medium
and treated with 1-naphthaleneacetic acid (NAA, a synthetic
analog of auxin) or left untreated. Cells were then harvested 0.5, 3
and 4 hours after the addition of NAA, and the expression of
AIDtTA was examined by Western blotting using a monoclonal
Table 1. Destination vectors created in this study.
Plasmid Marker GenBank Acc. No.
pDEST413TEFt7 HIS3 JX901379
pDEST414TEFt7 TRP1 JX901380
pDEST415TEFt7 LEU2 JX901381
pDEST416TEFt7 URA3 JX901382
pDEST413CYC1t7 HIS3 JX901383
pDEST414CYC1t7 TRP1 JX901384
pDEST375 URA3, MET15*1 KC614689
*159 and 39 flanking sequences of MET15.
doi:10.1371/journal.pone.0064419.t001
Table 2. Entry clones created in this study.
Plasmid Promoter
pYS1 S. cerevisiae CUP1
pYS2 S. pombe ADH1
pYS3 S. cerevisiae TEF
pYS6 TetO7 -CYC1TATA
pYS7 TetO2 -CYC1TATA
Plasmid ORF
pCG32 yEGFP
pDHM7 PESTyEGFP-Cln2
pCG55 yEVenus
pYS61 yEVenus-NLS*1
pCG98 yEVenus-Cln2PEST -NLS
pCG40 mCherry
pYS60 mCherry-NLS
pYS19 tTA
pYS20 rtTA
pYS58 AIDtTA
pYS57 AIDrtTA
pCG72 OsTIR1-9Myc
Promoter Entry clones were created with pDONR221P5-P2 and ORF Entry
clones with pDONR221P1-P5r.
*1Significant cytoplasmic fluorescence was observed when overexpressed, for
example, by TEF promoter.
doi:10.1371/journal.pone.0064419.t002
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anti-TetR antibody (Fig. 5A and B; note that different anti-TetR
and anti-Myc antibodies were used in panel A and B ). As shown
in Fig. 5A, AIDtTA was efficiently degraded by 3 hours following
the addition of NAA. This degradation depended on the
expression of OsTIR1 (tagged with 9xMyc epitope). The AID
was also required for the degradation as the expression of
untagged tTA was not affected in YS114 strain in the presence of
NAA (Fig. 5B). Likewise, AIDrtTA was degraded in NAA-
dependent manner in YS114 strain (with OsTIR1), but not in
YS129 (without OsTIR1) (Fig. 5C). When AIDrtTA was expressed
by the strong TEF promoter in YS114 strain, a fraction of
AIDrtTA protein remained intact even 4 hours after the addition
of NAA to the medium (Fig. 5D).
Next, we verified the activity of AIDtTA as a transcriptional
activator. YS129 yeast strain was transformed with the reporter
plasmid construct pCG87 (TetO7 -mCherry-NLS; mCherry
fluorescent protein reporter construct) together with pCG84
(ADH1-tTA) or pDHM19 (ADH1-AIDtTA). As shown in Fig. 6,
tTA and AIDtTA are active in the absence of doxycycline
(2DOX). Because tTA or AIDtTA activity is supposed to be
suppressed in the presence of DOX, mCherry reporter fluores-
cence should be reduced after treating cells with DOX. After 7
hours following the addition of DOX to the medium, however,
significant fluorescence still remained (Fig. 6B and C, +DOX).
This is presumably because the half-life of mCherry is relatively
long and it may take longer to see the reduction of the fluorescence
after addition of DOX, which is consistent with the results of flow
cytometry (see below).
We asked whether any rapid reduction of fluorescence after the
suppression of AIDtTA activity by DOX and NAA can be
achieved using yEVenus-Cln2PEST as a reporter. For this, we used
a diploid strain (JW003) with a copy of ADH1-OsTIR1 and a
reporter TetO7 -yEVenus-Cln2PEST genes integrated in the
genome. JW003 was transformed with pDHM19 (ADH1-AIDtTA).
Note that both AIDtTA and OsTIR1 was expressed by constitu-
tively active ADH1 promoter. The yeast cells were then cultured in
the presence or absence of NAA or DOX alone, or both together.
Fig. 7A shows a schematic diagram of the gene regulation by
AIDtTA in this strain. Without the inducers DOX or NAA, Venus
(YFP) fluorescence was clearly visible in the nucleus (Fig. 7B). Cells
without the plasmid (pDHM19; ADH1-AIDtTA) showed no
fluorescence (data not shown). After 1 hour of treatment with
DOX, NAA or both, no obvious decrease of fluorescence was
observed (Fig. 7C, upper left panels). The addition of DOX took
effect in 2 hours, with much reduced fluorescence in the presence
of the inducer either alone or together with NAA (Fig. 7C, upper
right panels). It took 3 hours for NAA alone to suppress effectively
the expression of the reporter yEVenus-Cln2PEST (Fig. 7C, lower
left panels). By 4 hours after the addition of the inducers,
fluorescence was greatly reduced in all cases (Fig. 7C, lower right
panels). The cells treated with both DOX and NAA showed more
pronounced reduction of fluorescence than those with either DOX
or NAA alone. These results indicate that AIDtTA activity can be
Figure 2. Gene assembly by Gateway LR recombination reaction. Yeast expression vectors can be created by one-step recombination
reaction using a promoter entry clone, an ORF entry clone and a Destination vector. In the LR reaction, CmR and ccdB selection marker genes flanked
by attR1 and attR2 are replaced by the assembled gene (promoter-ORF).
doi:10.1371/journal.pone.0064419.g002
Figure 1. Gateway Destination vectors constructed in this
study. (A) Yeast centromere Destination vectors. Each vector contains
ARSH4, CEN6, and a marker gene for maintenance in yeast. (B) Yeast
integration Destination vector (pDEST375). All vectors have an origin of
replication in E.coli (ori), attR1 and attR2 recombination sequences for
Gateway LR reaction, ampicillin resistance (AmpR), chloramphenicol
resistance (CmR) and ccdB selection marker genes for cloning. attR1 and
attR2 are flanked by TEF or CYC1 terminator (T) and T7 terminator (Tt7)
sequences as indicated.
doi:10.1371/journal.pone.0064419.g001
Yeast Vectors for Gene Assembly and Expression
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controlled efficiently by DOX and NAA. DOX took effect faster
than NAA perhaps partly because DOX directly inhibits the
reporter gene induction by AIDtTA while NAA acts indirectly by
promoting the degradation of AIDtTA. We tested two concen-
trations of NAA at 0.5 mM and 2 mM: increasing the concen-
tration of NAA did not accelerate the reduction of the fluorescence
(the results with 2 mM NAA is shown in Fig. 7). We also
performed a similar experiment using YS114 strain (with an
Figure 3. Gateway vector pDEST375 for chromosomal integration. pDEST375 harbors YIp-In and YIp-Out sequences derived from the
flanking region of MET15 gene. An integration vector made by an LR reaction is first linearized by MluNI (MscI), which is transformed into yeast cells. It
produces a single-copy integration of the gene of interest at the MET15 locus. At this stage, the genotype is URA3zMET15z. The chromosomal
MET15 gene and the flanking plasmid sequences including the URA3 marker gene are removed by homologous recombination between the
duplicated YIp-Out sequences. After this recombination event in vivo, the desired genotype of the strain with the stable integrated gene (promoter-
ORF) is ura3{met15{. The other possible genotype without the integrated gene after the recombination is ura3{MET15z (strains with this
genotype will be discarded). It enables a recycling of URA3 marker gene for subsequent gene integrations at other loci in the genome.
doi:10.1371/journal.pone.0064419.g003
Table 3. Expression plasmid vectors constructed by Gateway recombination method in this study.
Plasmid Promoter ORF Marker Destination vector
pCG52 S. cerevisiaeTEF mCherry LEU2 pDEST415TEFt7
pCG109 S. pombe ADH1 mCherry-NLS TRP1 pDEST414TEFt7
pCG57 S. cerevisiae TEF yEVenus LEU2 pDEST415TEFt7
pRN1 S. pombe ADH1 yEVenus-NLS LEU2 pDEST415TEFt7
pDHM57 S. pombe ADH1 yEVenus-Cln2PEST-NLS LEU2 pDEST415TEFt7
pCM25 S. cerevisiae CUP1 yEVenus-Cln2PEST-NLS LEU2 pDEST415TEFt7
pCG87 TetO7-CYC1TATA mCherry-NLS TRP1 pDEST414TEFt7
pCG103 TetO7-CYC1TATA yEVenus-Cln2PEST-NLS TRP1 pDEST414TEFt7
pCM20 TetO7-CYC1TATA yEVenus-Cln2PEST-NLS TRP1 pDEST415TEFt7
pCG84 S. pombe ADH1 tTA HIS3 pDEST413TEFt7
pCG85 S. pombe ADH1 rtTA HIS3 pDEST413TEFt7
pDHM19 S. pombe ADH1 AIDtTA HIS3 pDEST413TEFt7
pDHM20 S. pombe ADH1 AIDrtTA HIS3 pDEST413TEFt7
pCG112*1 S. cerevisiae TEF tTA HIS3 pDEST413TEFt7
pCG113 S. cerevisiae TEF rtTA HIS3 pDEST413TEFt7
pCG106*1 S. cerevisiae TEF AIDtTA HIS3 pDEST413TEFt7
pCG107 S. cerevisiae TEF AIDrtTA HIS3 pDEST413TEFt7
pMM6*2 S. cerevisiaeTEF AIDrtTA URA3, MET15 pDEST375
pCG81 S. pombe ADH1 OsTIR1-9Myc URA3 pDEST416TEFt7
*1Yeast cells with these expression vectors showed poor growth with an unknown reason.
*2Integration vector.
doi:10.1371/journal.pone.0064419.t003
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integrated ADH1-OsTIR1) transformed with two plasmids
pDHM19 (ADH1-AIDtTA) and pCG103 (TetO7 -yEVenus-
Cln2PEST ): similar profile of reduction in fluorescence was
observed after cells were treated with DOX and NAA, although
the level of fluorescence was more heterogeneous across the cell
population in all conditions tested than that in JW003 strain (data
not shown).
The same set of yeast strains used in Fig. 6, i.e., YS129 or
YS114 with two vectors pCG87 (mCherry reporter plasmid) and
pCG84 (ADH1-tTA) or pDHM19 (ADH1-AIDtTA) were subjected
to flow cytometry to examine the gene expression control by
AIDtTA (Fig. 8A–C). Cells were treated with either doxycycline
(+DOX; broken green lines) or NAA alone (+NAA; cyan), or both
(+DOX & NAA; orange) for 7 hours, or left untreated (no
inducers; broken magenta). Consistent with the observation by
fluorescence microscopy (Fig. 6), tTA and AIDtTA were equally
active in the absence of doxycycline and NAA (broken magenta
lines in Fig. 8A–C), and induced the expression of the mCherry
reporter fluorescent protein. After addition of DOX (broken green
lines), the fluorescence of the reporter decreased as expected for
both strains expressing tTA and AIDtTA. A large fraction of cells,
however, have the fluorescence well above the basal level of the
reporter plasmid (v102 arbitrary fluorescence units, data not
shown). In the presence of NAA (cyan lines), the mCherry
expression decreased only in the cells with both AIDtTA and
OsTIR1 expressed (Fig. 8C). These results are consistent with the
NAA- and OsTIR1-dependent degradation of AIDtTA detected
by Western blots (Fig. 5A and B).
We also tested the doxycycline-dependent gene expression by
AIDrtTA and its degradation in OsTIR1- and NAA-dependent
manner (Fig. 9). The YS114 (with OsTIR1) and YS129 (without
OsTIR1) strains transformed with the plasmids pCG87 (mCherry
reporter construct) and pCG107 (TEF-AIDrtTA) (Fig. 9A) were
cultured in the presence or absence of DOX or NAA for 5 hours,
and observed by fluorescence microscopy (Fig. 9B). Expression of
the fluorescent reporter mCherry was detected in response to
+DOX in both YS114 and YS129 strains (Fig. 9B, middle panels).
In contrast, when DOX was added to the cell together with NAA
(+DOX&NAA), the reporter expression was inhibited in YS114
strain (Fig. 9B, right bottom panels). The expression of mCherry
was not affected in the absence of OsTIR1 after addition of NAA
(Fig. 9B, left bottom panels). DOX-dependent expression of
reporter fluorescent proteins was also observed using the strain
with an integrated copy of TEF-AIDrtTA (MM017; Fig. 9C).
Those yeast strains used for fluorescence microscopy were also
examined by flow cytometry (Fig. 8D–F). The results confirmed
the DOX-dependent activation (green broken line) by AIDrtTA
(Fig. 8E and F). The data also demonstrated the NAA-dependent
reduction (orange line) of fluorescent reporter proteins in cells
expressing AIDrtTA and OsTIR1 (Fig. 8F). In Fig. 8D–F, the data
for cells treated with NAA alone are not shown, which have similar
distribution of fluorescence as those of untreated ones (No
inducers; broken magenta lines). YS129 (the strain without
OsTIR1) with TEF-AIDrtTA showed around five fold decrease in
fluorescence when DOX was added together with NAA (Fig. 8E,
green broken and orange lines); the reason for this reduction in
Figure 4. Fluorescent protein gene induction by CUP1 and ADH1 promoter. (A) Yeast cells (YS129 strain) transformed with pCM25 (CUP1-
yEVenus-Cln2PEST -NLS) were cultured in the presence or absence of copper nitrate for 1 hr (middle panels) and 6 hrs (bottom panels). Cells with no
copper nitrate are also shown in the upper panel. (B) Yeast cells (YS129) with pDHM57 (ADH1-yEVenus-Cln2PEST -NLS). (C) Yeast cells (YS129) with
pRN1 (ADH1-yEVenus-NLS). Note that the fluorescence images in (B) and (C) were captured with the same exposure time. DIC: differential interference
contrast; YFP: YFP filter channel for the detection of Venus fluorescence. Scalebar~5mm.
doi:10.1371/journal.pone.0064419.g004
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fluorescence remains unknown. We also found that when rtTA
expression was induced by the strong promoter TEF, it activated
the reporter gene in the absence of DOX (Fig. 8D, magenta
broken line). Such spurious DOX-independent activation of the
TetO promoter by rtTA was not observed when its expression was
induced by moderate ADH1 promoter (data not shown).
Discussion
In this study, we have created a set of versatile Gateway
Destination vectors and a collection of promoter and ORF Entry
clones to facilitate gene network construction. The multisite
Gateway technology enables the efficient assembly of a promoter
and an ORF in a one-step recombination reaction in vitro. An
expression vector generated by this method can readily be
introduced into yeast for functional assays of the assembled gene.
A similar combinatorial approach was demonstrated to be an
efficient method for producing diverse phenotypes of synthetic
networks in E. coli [14]. The Destination vector pDEST375
described above allows a stable single-copy integration of an
artificial gene at MET15 locus, adding a flexible option for
engineering artificial gene networks in yeast. We plan to construct
similar Gateway vectors for integration at the other chromosome
locus utilized by Sadowski et al. [7], such as ADE8, FCY1 and
LYS2.
The collection of Entry clones for our gene assembly strategy
may be expanded to include a number of other biological parts
which has already been characterized and available for synthetic
biology applications. For instance, DNA fragments encoding a
subset of BioBrick standard biological parts (http://partsregistry.
org/) [15] could be converted into Entry clones by PCR
amplification using the prefix and suffix sequences that flank
every BioBrick part, followed by Gateway BP recombination
reactions. Although the Entry clones presented here are for two-
fragment recombinations, the Destination vectors can be used for
recombination reactions of three or more DNA fragments. This
would be useful for the assembly of a gene with a complex
promoter.
In an effort to increase the flexibility of synthetic gene networks
in yeast, we have also constructed two new tunable transcriptional
transactivators, AIDtTA and AIDrtTA. We showed that when O.
sativa TIR1 gene is co-expressed, they were rapidly degraded in
response to auxin. We also demonstrated that the expression of the
reporter gene by AIDtTA and AIDrtTA were controlled efficiently
by NAA and/or DOX added to the medium (Fig. 6–9). We
constructed a destabilized version of Venus, yEVenus-Cln2PEST,
and used it to monitor the AIDtTA’s activity (Fig. 7). Because
Venus has faster, improved maturation properties of the chromo-
phore [16], yEVenus-Cln2PEST may be better-suited than the
original version, GFP-Cln2PEST [10], as a reporter of the dynamics
of synthetic gene networks. A unique advantage of AIDtTA or
AIDrtTA may be that the ‘memory’ of gene activation can be
erased rapidly by an auxin-regulated protein degradation. The
rapid degradation of these transactivators are however dependent
on the fine balance of their expression level and that of Tir1
protein: when AIDrtTA was expressed by the strong TEF
Figure 5. Auxin-induced degradation of AIDtTA and AIDrtTA detected by Western blotting. OsTIR1 is tagged with 9xMyc epitope. Cells
were treated with NAA or left untreated for the periods as indicated. (A) The yeast strain with an integrated copy of OsTIR1 gene (::ADH1-OsTIR1;
YS114 strain) and ADH1-AIDtTA plasmid. (B) Control strain YS129 with ADH1-AIDtTA, YS114 with ADH1-tTA, and YS114 with ADH1-AIDtTA plasmid. (C)
YS129 and YS114 with ADH1-AIDrtTA plasmid. (D) YS129 with TEF-AIDrtTA, YS114 with TEF-rtTA and YS114 with TEF-AIDrtTA plasmid. Cells were
harvested and subjected to Western blotting using anti-TetR (a{TetR, for tTA, AIDtTA, rtTA and AIDrtTA) and anti-Myc (a{Myc, for OsTIR1)
antibodies. Note that different primary antibodies were used in Fig. 5A (indicated by *1 and *2) and B–D (*3 and *4); see Materials and Methods.
Arrowheads indicate non-specific proteins recognized by the primary antibodies, which act as loading controls.
doi:10.1371/journal.pone.0064419.g005
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promoter, its degradation was retarded (Fig. 5D). The AID system
therefore requires fine-tuning of the expression level of its
components to achieve the desired functionality. For example,
the expression level of OsTIR1 in yeast may be increased by
adopting a codon-optimized version of the ORF [17], thereby
improving the efficiency of the degradation of AID-tagged target
proteins.
An additional control may also be integrated into synthetic
networks using these engineered transactivators by making the
TIR1 gene expression inducible. AIDtTA and AIDrtTA should
also be functional in other eukaryotic systems in principle, as AID
system and the tetracycline-regulated transactivators were dem-
onstrated to work in higher eukaryotic cells [8,9]. Because of the
dominance of the auxin-induced degradation over the doxycy-
cline-regulated gene induction, AIDtTA and AIDrtTA may
function as Boolean logic devices in response to doxycycline and
auxin, corresponding to NOR and N-IMPLY gate, respectively.
Recent work has also exploited post-transcriptional negative
regulations to perform logic operations NOT, AND, NAND and
N-IMPLY, using RNA binding proteins that inhibit the translation
of transcripts harboring specific RNA motifs [18]. AIDtTA and
AIDrtTA may be combined together with other biological logic
operation devices in eukaryotes [18–21].
The budding yeast Saccharomyces cerevisiae is an attractive system
for synthetic biology because of its vast resources and tools for
biotechnology applications. Moreover, S. cerevisiae has been
exploited as a platform for synthesizing a complete genome
[22,23] and chromosome arms [24]. These studies have presented
a prospect of engineering a large-scale artificial gene network in
yeast. Although the number of biological parts customized for
yeast synthetic biology is still limited, it is rapidly growing in recent
years [25–27]. The multisite Gateway recombination method for
assembling artificial genes may be a useful addition to the toolbox
for synthetic biology in yeast and also a valid approach in other
organisms.
Materials and Methods
Yeast Manipulations, Strains and Media
Genetic manipulations and transformations of yeast cells were
performed as described [28]. After transformation, cells were
plated on synthetic complete medium (SC) lacking appropriate
amino acids [28]. Transformed cells with plasmids were cultured
in the selective media until the culture reaches early to mid-log
phase of growth (OD600~0:1*1:0) for experiments. The yeast
strains used in this study are FY1679 (MATa=aGAL2=
GAL2HIS3=his3D200LEU2= leu2D1TRP1=trp1D63ura3{52=
ura3{52; EUROSCARF Acc. No. 10000D), YS114
(MATaGAL2his3D200trp1D63ura3{52 :: ADH1{OsTIR1{
9Myc,URA3; this study), MM017 (MATahis3D1leu2D0trp1D63
ura3D0met15 :: TEF{AIDrtTA; this study), YS008 (MATahis3
D1leu2D0trp1D63ura3D 0met15 :: ADH1{OsTIR1{ 9Myc;
this study), YS017 (MATahis3D1leu2D0trp1D63ura3D
0lys2 : : TetO7{CYC1TATA{ yEVenus{Cln2PEST{NLS;
this study), YS081 (MATahis3D1leu2D0trp1D63ura3D0; this
study), JW003 (MATa=ahis3D1=his3D1leu2D0=leu2D0trp1D63
= trp1D63ura3D0=ura3D0met15 :: ADH1{OsTIR1{ 9Myc=
MET15LYS2=lys2 :: TetO7{CYC1TATA{ yEVenus{Cln
Figure 6. Fluorescent reporter protein expression induced by AIDtTA. YS129 strain was transformed with the plasmid constructs indicated
above each panel. The activity of tTA and AIDtTA was detected by mCherry fluorescent reporter protein expression. (A) TetO7 -mCherry-NLS (reporter
plasmid) only, without doxycycline (2DOX). (B) ADH1-tTA and TetO7 -mCherry-NLS. (C) ADH1-AIDtTA and TetO7 -mCherry-NLS. Cells were observed
7 hrs after addition of DOX. DIC: differential interference contrast; mCherry: mCherry fluorescence was detected using TRITC filter. Scalebar~5mm.
doi:10.1371/journal.pone.0064419.g006
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2PEST{NLS; this study) and YS129 (MATahis3
D1leu2D0trp1D63ura3D0; this study), which are all congenic with
S288C. To integrate the Oryza sativa TIR1 gene, pNHK53 (an
integration vector of ADH1-OsTIR1-9Myc) [8] was linearized by
StuI and transformed into FY1679. To derive YS114, the diploid
strain with an integrated pNHK53 was sporulated. Sporulations
were performed as follows: Freshly streaked cells on YPD plate
were patch-streaked on GNA (5% glucose, 3% Difco nutrient
broth (BD Bioscience; cat. no. 234000), 1% yeast extract, 2%
bacto-agar) and incubated overnight at 30uC. The cells on GNA
were patch-streaked again on GNA and incubated overnight at
30uC. A small quantity of cells (equivalent to a medium-sized
colony on a plate) was then suspended in 2.5 ml of sporulation
medium (1% pottasium acetate, 0.5% zinc acetate) and incubated
at 25uC with vigorous shaking for up to a week. The genetic
selection of YS008, YS017 and MM017 strains were performed
according to Sadowski et al. [7], which describes the detailed
methods of gene integration and disintegration. To create
MM017, pMM6 (Table 3) was linearized with MluNI (an
isoschizomer of MscI) and transformed into YS129 for integration.
To derive YS008, pCM33 (integration vector of ADH1-OsTIR1-
9Myc; see below for its construction) was linearized by MluNI and
transformed into YS129 for integration. To make YS017, pCM36
(TetO7 -CYC1TATA-yEVenus-Cln2PEST -NLS; see below for its
construction) was linearized by NruI and transformed into
YS081 strain. JW003 strain was made by mating YS008 and
Figure 7. Suppression of AIDtTA activity by doxycycline and NAA. The yeast strain with an integrated copy of ADH1-OsTIR1 and a reporter
TetO7 -yEVenusCln2PEST -NLS gene was transformed with the plasmid harboring ADH1-AIDtTA. The fluorescent reporter protein expression was
examined in the presence or absence of DOX and NAA as indicated. (A) Schematic diagram of the gene network of the strain. (B) Expression of
yEVenusCln2PEST in the absence of DOX and NAA. (C) Expression of yEVenusCln2PEST after treatment with DOX or NAA alone or both for 1, 2, 3 and 4
hours. DIC: differential interference contrast; YFP: YFP filter channel. Scalebar~5mm.
doi:10.1371/journal.pone.0064419.g007
Figure 8. Gene expression control by AIDtTA and AIDrtTA: flow cytometry analysis. (A–F) The yeast strains YS129 (-OsTIR1) and YS114
(+OsTIR1) were transformed with a reporter plasmid construct (TetO7 -mCherry-NLS) together with the plasmid harboring the gene as labeled on
each panels. These transformed yeast cells were treated with either doxycycline (+DOX; broken green lines) or NAA alone (+NAA; cyan), or both
(+DOX & NAA; orange) for 7 hours, or left untreated (no inducers; broken magenta), and analyzed by flow cytometry. Fluorescence of 50,000 cells for
each sample were measured. The data were gated to remove those of cell debris and aggregates, binned in log scale (0to105,100bins) and plotted.
The plots are offset at fluorescence= 4 arbitrary units.
doi:10.1371/journal.pone.0064419.g008
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YS017. JW003 transformed with the plasmid pDHM19 (ADH1-
AIDtTA) was used for the experiment shown in Fig. 7.
To test the regulation of AIDtTA and AIDrtTA by doxycycline
and auxin (Fig. 5 to 9), YS114, MM017 and YS129 strains were
transformed with pCG103 (TetO7 -CYC1TATA-yEVenus-Cln2PEST -
NLS), pCG87 (TetO7 -CYC1TATA-mCherry-NLS), pCG84 (ADH1-
tTA), pDHM19 (ADH1-AIDtTA), pCG85 (ADH1-rtTA), pDHM20
(ADH1-AIDrtTA), pCG113 (TEF-rtTA), and pCG107 (TEF-
AIDrtTA) as indicated in each figure. Doxycycline (DOX) was
added to cell cultures at the final concentration of 5mg=ml. For the
induction of protein degradation using AID system, 1-Naphtha-
leneacetic acid (NAA; pottasium salt, Sigma cat. no. N1145) was
added to cell cultures to 0.5 mM, except the experiment shown in
Fig. 7 in which 2 mM was used. We observed little inhibition of
cell growth up to 2 mM of NAA. Phosphate-citrate buffer
(64.2 mM Na2 HPO4 and 17.9 mM citric acid, pH6.0) was added
to SC medium to prevent the acidification of the culture [29] when
using NAA. To induce CUP1 promoter, copper nitrate (Cu(NO3)2,
Sigma cat. no. 223395) was added to the medium to 0.25 mM.
DOX, NAA, or copper nitrate were added to cell cultures at
OD600 = 0.2.
Molecular Biology Techniques
Standard molecular biology techniques were used for DNA
manipulations. DNA fragments were purified using a PCR
purification kit or gel purification kit (Qiagen). DNA ligation
was performed using a rapid DNA ligation kit (Roche Applied
Science). For PCR reactions, Pfu polymerase (Promega) or
Velocity DNA polymerase (Bioline) were used. PCR primers used
in this study are listed in Table 4. Plasmid clones created with
PCR reactions were verified by DNA sequencing. The Gateway
recombination reactions were performed using Multisite Gateway
Pro Kits (Life Technologies). The donor vectors (pDONR221P1-
P5r, pDONR221P5-P2; Life Technologies), and destination
vectors were prepared using ccdB Survival T1R Chemically
Competent E. coli (Life Technologies).
Construction of destination vectors. The destination
vectors containing a yeast centromere were built upon the pRS
vector series (pRS413, pRS414, pRS415 and pRS416) [6]. A.
gossypii TEF terminator was amplified by PCR from pAG25 [30],
using the standard T7 sequencing primer and TEFt-F primer. The
amplified DNA was cut with NotI and SacI and cloned into the
pRS vectors to create pRS413TEFt, pRS414TEFt, pRS415TEFt
and pRS416TEFt. S. cerevisiae CYC1 terminator was amplified from
pCM183 [31] by PCR with CYC1F and CYC1R primers, cut
Figure 9. Gene expression control by AIDrtTA. (A) Schematic representation of the experimental system. AIDrtTA activity was detected by
mCherry fluorescent reporter protein expression. (B) Yeast strains as indicated were cultured in the presence of doxycycline (+DOX), auxin (+NAA),
both doxycycline and auxin (+DOX & NAA), or in the absence (no inducer). Cells were observed 6 hrs after addition of the inducers. (C) Yeast strain
with an integrated copy of TEF-AIDrtTA (MM017) was cultured in the presence or absence of doxycycline for 5 hours. DIC: differential interference
contrast; mCherry: mCherry fluorescence detected with TRITC filter. Scalebar~5mm.
doi:10.1371/journal.pone.0064419.g009
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with NotI and SacI and cloned into the pRS413 vector digested
with the same enzymes to create pRS413CYC1T. A cassette
containing two recombination sites, attR1 and attR2, flanking the
ccdB and CmR (chloramphenicol resistance) genes was amplified by
PCR from pDEST17 (Invitrogen), using primers attR1-F and
attR2-R. The PCR product was digested by SpeI and AvrII and
cloned into pRS413CYC1T to yield pDEST413CYC1T. The
attR1-attR2 cassette with the ccdB and CmR genes was cut out
from pDEST413CYC1T by XhoI and XbaI and cloned into
pRS413TEFt, pRS415TEFt and pRS416TEFt, which yielded
pDEST413TEFt, pDEST415TEFt and pDEST416TEFt, respec-
tively. To create pDEST414TEFt, 2 kb DNA fragment containing
the cassette and the TEF terminator was cut out from
pDEST413TEFt by XhoI and SacI and ligated to pRS414
digested with the same enzymes. Similarly, the XhoI-SacI DNA
fragment from pDEST413CYC1T was cloned into pRS414 to
make pDEST414CYC1t. Although these pDEST plasmids were
functional as destination vectors, T7 terminator downstream of
ccdB gene was found to be required for efficient selection of
expression clones. Therefore, DNA fragments harbouring the T7
terminator were cut out from pDEST17 and cloned into these
vectors, to create pDEST413TEFt7, pDEST414TEFt7,
pDEST415TEFt7, pDEST416TEFt7, pDEST413CYC1t7 and
pDEST414CYC1t7 (Fig.1). pDEST375 was made by isolating the
KpnI/SacI DNA fragment containing the Gateway attR1-attR2
cassette from pDEST416TEFt7 and cloning it into pIS375 [7]
using the same restriction sites.
Construction of promoter entry clones. S. cerevisiae CUP1
promoter was amplified by PCR from pYM-N1 [11] using the
oligonucleotide primers B2-CUP1-F and B5-CUP1-R. S. pombe
ADH1 promoter was amplified from pCM245 [32] using B2-
ADH-F and B5-ADH-R primers. S. cerevisiae TEF promoter was
amplified from pYM-N18 [11] using the primers B2-TET-F and
Table 4. PCR primers.
Primer Sequence
T7 TAATACGACTCACTATAGGG
TEFt-F TTGCGGCCGCTCAGTACTGACAATAAAA
CYC1F AAGCGGCCGCATCATGTAATTAGT
CYC1R TTGAGCTCAAATTAAAGCCTTCGAGCGT
attR1-F ACCACTAGTACAAGTTTGTACAAAAAAGC
attR2-R GTTCCTAGGACCACTTTGTACAAGAA
B2-CUP1-F GGGGACCACTTTGTACAAGAAAGCTGGGTATAGTAAGCCGATCCCATTAC
B5-CUP1-R GGGGACAACTTTGTATACAAAAGTTGCTCTGTCGTCCGGATTTATGTGATG
B2-ADH-F GGGGACCACTTTGTACAAGAAAGCTGGGTAGCATGCCCTACAACAACTAA
B5-ADH-R GGGGACAACTTTGTATACAAAAGTTGGCAATTCTCTTGCTTAAAGAAAAGC
B2-TET-F GGGGACCACTTTGTACAAGAAAGCTGGGTAGAGCTCATAGCTTCAAAATG
B5-TET-R GGGGACAACTTTGTATACAAAAGTTGAAAACTTAGATTAGATTGCTATGCT
B2TetO-1 GGGGACCACTTTGTACAAGAAAGCTGGGTAGGCAGATCAATTCCTCGATC
B5TetO-1 GGGGACAACTTTGTATACAAAAGTTGTAATTTAGTGTGTGTATTTG
B5r-tTA GGGGACAACTTTTGTATACAAAGTTGTACAACATGTCTAGATTAGATAAAAG
B1-tTA GGGGACAAGTTTGTACAAAAAAGCAGGCTCTACCCACCGTACTCGTCA
AIDtTA-F GGTGCAGGCGCTGGAGCGGGTGCCATGTCTAGATTAGATAAAAGTAAA
AIDtTA-R TTTACTTTTATCTAATCTAGACATGGCACCCGCTCCAGCGCCTGCACC
B5r-AIDGFPNLS GGGGACAACTTTTGTATACAAAGTTGTACAAAATGATGGGCAGTGTCGAG
B5r-yEGFP-F2 GGGGACAACTTTTGTATACAAAGTTGTACAAAATGTCTAAAGGTGAAGAATTATTC
B1-yEGFP-R2 GGGGACAAGTTTGTACAAAAAAGCAGGCTTTATTTGTACAATTCATCCATACC
B1-yVenus-R2 GGGGACAAGTTTGTACAAAAAAGCAGGCTTTATTTGTACAATTCATCAATACC
B1-Cln2PEST GGGGACAAGTTTGTACAAAAAAGCAGGCTCTAGCTATATTACTTGGGTATTGC
B1-yEGFPNLS-R GGGGACAAGTTTGTACAAAAAAGCAGGCTGGTACCTCAGTCGACTTTTCTCTTTTT-
CTTTGGACCACCACCCCCGGGTTTGTACAATTCATCCATACC
B5r-mCherry-F1 GGGGACAACTTTTGTATACAAAGTTGTACAAAATGGTGAGCAAGGGCGAGGA
B1-mCherry-R1 GGGGACAAGTTTGTACAAAAAAGCAGGCTTTACTTGTACAGCTCGTCCA
B1-mCherryNLS-R GGGGACAAGTTTGTACAAAAAAGCAGGCTGGTACCTCAGTCGACTTTTCTCTTTTT-
CTTTGGACCACCACCCCCGGGCTTGTACAGCTCGTCCATGCC
XmaI-PESTF ATACCCCGGGTCTGGTGGTACCGCATCCAACTTGAACATTTC
XmaI-PESTR TCAACCCGGGACCACCTATTACTTGGGTATTGCCCATACC
B5r-TIR1 GGGGACAACTTTTGTATACAAAGTTGTACAAAATGACGTACTTCCCGGAG
B1-TIR1 GGGGACAAGTTTGTACAAAAAAGCAGGCTTTAGCTAGTGGATCCGTT
PCR primers used in this study. Sequences are in 5
0
to3
0
direction.
doi:10.1371/journal.pone.0064419.t004
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B5-TET-R. A DNA fragment containing TetO2 operator with the
TATA region of S. cerevisiae CYC1 gene (CYC1TATA) was amplified
from pCM171 [31] using the primers B2TetO-1 and B5TetO-1.
Likewise, TetO7 with CYC1TATA was amplified from pCM159
[31] using the same pair of primers. These PCR products were
purified and subjected to BP recombination reaction with
pDONR221P5-P2 in vitro to create the plasmids listed in Table 1.
Construction of ORF entry clones. yEGFP ORF was
amplified from pYM25 [11] using the primers B5r-yEGFP-F2 and
B1-yEGFP-R2. yEGFP-Cln2PEST ORF was obtained by PCR
from pSVA13 [10] using B5r-yEGFP-F2 and B1-Cln2PEST.
yEVenus ORF was amplified by PCR from pKT90 [33] using the
primers B5r-yEGFP-F2 and B1-yVenus-R2. mCherry ORF were
amplified from pCS-memb-mCherry (mCherry fused to a
myristoylation motif; a kind gift from J.C. Smith, originally
constructed by S. Megason and S. Fraser, Caltech), using B5r-
mCherry-F1 and B1-mCherry-R1 primers. A glycine linker and a
SV40 nuclear localization signal (NLS; amino acid sequence
PGGGGPKKKRKVD) was added to the C-terminus of yEVenus
ORF by PCR using the primers B5r-yEGFP-F2 and B1-
yEGFPNLS-R and pKT90 as a template. Likewise, mCherry-
NLS was constructed by PCR using the primer pair B5r-mCherry-
F1 and B1-mCherryNLS-R, and pCG40 as a template. The
plasmid for yEVenus-Cln2PEST (pCG98) was created by inserting
a Cln2PEST XmaI fragment into pYS61. The Cln2PEST sequence
was amplified by PCR using primers XmaI-PESTF and XmaI-
PESTR, and pSVA13 as a template. tTA and rtTA ORFs were
amplified from pCM171 [31] and pCM251 [32] respectively,
using the primers B5r-tTA and B1-tTA. To create pCG72,
OsTIR1-9Myc was amplified by PCR using primers B5r-TIR1
and B1-TIR1, and pNHK36 [8] as a template. The amplified
ORFs were cloned into pDONR221P1-P5r by Gateway BP
reaction to create the Entry clones in Table 2. Auxin inducible
degron (AID) was fused to tTA and rtTA using a method that
combines a Gateway BP reaction in vitro and a homologous
recombination in vivo in E. coli [13]. For this, two PCR reactions
were performed. First, a DNA fragment encoding AID was
amplified from pNHK12 [8] using the oligonucleotides AIDtTA-
R and B5r-AIDGFPNLS (PCR product 1). Second, tTA and rtTA
ORF were amplified using the primers AIDtTA-F and B1-tTA
(PCR product 2). PCR product 1 and 2 have an overlapping
sequence that mediates a homologous recombination in vivo. These
PCR products together with pDONR221P1-P5r were subjected to
a BP reaction, followed by a transformation into E. coli (DH5a
strain), to create pYS57 (Entry clone of AIDrtTA) and pYS58
(AIDtTA).
Other plasmids. The integration vector pCM33 was made
as follows: pCG81 (Table 3) was digested by SphI/BspQI and
blunt-ended by T4 DNA polymerase (New England Biolabs). The
fragment containing ADH1-OsTIR1-9Myc was purified and ligated
to pIS375 [7], which was linearized by BamHI and blunt-ended
by Klenow fragment (Promega). pCM36 was created by inserting
PvuII fragment of pCM20 (Table 3) into pIS385 [7], which was
cut by BamHI and blunt-ended by Klenow fragment. pNHK12,
pNHK36 and pNHK53 were obtained from the National Bio-
Resource Project (NBRP) of MEXT, Japan. The following
plasmids were obtained from EUROSCARF (EUROpean Sac-
charomyces Cerevisiae ARchive for Functional Analysis): pAG25,
pCM159, pCM171, pCM183, pCM245, pCM251, pIS375,
pKT90, pYM25, pYM-N1, pYM-N18.
Microscopy and Flow Cytometry
Yeast cells were cultured in liquid SC medium lacking
appropriate amino acids and mounted on a glass slide for
fluorescence microscopy. Images were acquired using a Zeiss
Axioplan2 microscope with an oil-immersion objective lens (1006)
equipped with a CCD camera (Hamamatsu ORCA-ER) and
Openlab software (Perkin Elmer). For flow cytometry, cells were
harvested by centrifugation, or by vacuum filtration on nitrocel-
lulose membranes (1:2mm, Millipore, cat. no. RAWP02500), re-
suspended in ice-cold 16PBS and sonicated briefly before
subjected to the analysis using LSRFortessa (BD Biosciences).
Fluorescence of 50,000 cells for each sample were measured by
flow cytometry. Based on the FFS/SSC values, the data were
gated to remove cell debris and aggregates. The raw data for the
remaining cells, between 86% and 98% of the original sample,
were exported to MATLAB (MATLAB, Natick, Massachusetts:
The MathWorks Inc., 2012) and binned in log scale
(0to105,100bins). The scale of each bin was normalized by the
sum of all cells in the respective sample and plotted (Fig. 8). No
smoothing has been applied.
Western Blotting
Protein extraction from yeast cells was conducted as described
[34]. Standard techniques were used for electrophoresis (SDS-
PAGE) and Western blotting. Western blotting was performed
using Amersham ECL Plus Western Blotting detection reagent (cat
no. RPN2132). The primary antibodies used were anti-myc
monoclonal (1:1000, Millipore, 9E10, *2 in Fig. 5A) or rabbit
polyclonal antibody (1:5000, Abcam, cat no. ab9106, *4 in
Fig. 5B–D) and TetR monoclonal antibody (1:1000, Clontech, cat
no. 631108, *1 in Fig. 5A; 1:1000, MoBiTec, TET02, *3 in
Fig. 5B–D); the secondary antibodies were anti-mouse IgG HRP-
linked antibody (1:1000, Cell Signaling #7076) and anti-rabbit
IgG HRP-linked antibody (1:1000, DAKO, cat no. P0217). Equal
loading of protein extracts in SDS-PAGE was verified by Ponceau
S staining of blotted membranes.
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